Copyright ©2017 Guacamoley. All rights reserved.
Danny Lawson - PA Images/Getty Images
US Drug Company Finds Cure For Rare Form Of Genetic Blindness—But It'll Cost You
4 months ago

Spark Theraputics, a pharmaceutical company, has just made an exciting discovery! They've discovered a cure for a rare, genetic form of retinal dystrophy that leaves its victims blind. 

There's just one problem: it's pretty expensive.

At $425,000 PER EYE, Luxturna is the most expensive drug ever marketed.

Gene therapies pose a unique threat to pharmaceutical companies because they need only one treatment before the patient is "cured."

Luxturna is the first gene therapy the FDA has approved.

Twitter users believe the drug should be available to anyone who needs it:

But Dr. Steve Miller, chief medical officer at a company that negotiates drug costs, told CBS: 

It's wildly expensive but, to be very frank, I think they've priced it what I'll call responsibly.

Jeff Marrazzo, chief executive at Spark, commented:

Our work is not done, but we believe that the offerings we are announcing today will help ensure that eligible U.S. patients have the coverage and financial support they need to gain access to both Luxtarna and the specialised medical care required to deliver the product at treatment centers.